ritonavir and Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma

ritonavir has been researched along with Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma* in 2 studies

Other Studies

2 other study(ies) available for ritonavir and Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma

Article	Year
Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-04, Volume: 76, Issue:5 A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had persistent, progressive pneumonia with viremia after 5 months of infection despite monoclonal antibodies, intravenous (IV) remdesivir and prolonged oral steroids. Twenty days of nirmatrelvir/ritonavir and 10 days of IV remdesivir led to full recovery. Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ritonavir; SARS-CoV-2	2023
COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia. British journal of haematology, 2020, Volume: 190, Issue:1 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Fatal Outcome; Female; Humans; Lopinavir; Meropenem; Middle Aged; Pandemics; Pneumonia, Viral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ritonavir; SARS-CoV-2; Teicoplanin	2020

Article

Year

Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-04, Volume: 76, Issue:5

A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had persistent, progressive pneumonia with viremia after 5 months of infection despite monoclonal antibodies, intravenous (IV) remdesivir and prolonged oral steroids. Twenty days of nirmatrelvir/ritonavir and 10 days of IV remdesivir led to full recovery.

Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ritonavir; SARS-CoV-2

2023

COVID-19 in a patient with pre-existing acute lymphoblastic leukaemia.

British journal of haematology, 2020, Volume: 190, Issue:1

Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Drug Combinations; Fatal Outcome; Female; Humans; Lopinavir; Meropenem; Middle Aged; Pandemics; Pneumonia, Viral; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ritonavir; SARS-CoV-2; Teicoplanin

2020